Giant cell arteritis with visual loss following zoledronic acid infusion

20137 citationsJournal Article

Authors

Samy Metyas · University of Southern California

Makary Ibrahim · Technology Focus (United States)

John Solyman · Technology Focus (United States)

Karen Yeter · University of Southern California

Daniel G. Arkfeld · University of Southern California

Abstract

Zoledronic acid is used in the treatment of osteoporosis. Giant cell artertitis may lead to vision loss. We report a case in which vision loss occurred after zoledronic acid infusion.

Topics & Keywords

Vasculitis and related conditions Systemic Lupus Erythematosus Research Otitis Media and Relapsing Polychondritis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Rheumatic Diseases

Volume 17, Issue 1, pp. 113-115

DOI: 10.1111/1756-185x.12263

Field-Weighted Citation Impact: 0.46